1. ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti–Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma. (20th January 2022) Authors: Zhang, Liangliang; Hamdani, Omar; Gjoerup, Ole; Cho-Phan, Cheryl; Snider, Jeremy; Castellanos, Emily; Nimeiri, Halla; Frampton, Garrett; Venstrom, Jeffrey M.; Oxnard, Geoffrey; Klempner, Samuel J.; Schrock, Alexa B. Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Natural History of Human Epidermal Growth Factor Receptor 2–Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical Practice. (21st March 2022) Authors: Schröder, Carsten; Gower-Page, Craig; Reyes-Rivera, Irmarie; Patel, Arisha; Price, Richard; Sen, Shiraj; Davies, Jessica; Castellanos, Emily; Snider, Jeremy; Bai, Xiaobo; Fisher, Virginia; Mhatre, Shivani K. Journal: JCO Clinical Cancer Informatics Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. RAS Amplification as a Negative Predictor of Benefit from Anti-EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer. (10th February 2021) Authors: Schrock, Alexa B.; Lee, Jessica K.; Sandhu, Jaideep; Madison, Russell; Cho-Phan, Cheryl; Snider, Jeremy W.; Castellanos, Emily; Venstrom, Jeffrey M.; Fakih, Marwan Journal: Oncologist Issue: Volume 26:Number 6(2021) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. RAS Amplification as a Negative Predictor of Benefit from Anti‐EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer. (10th February 2021) Authors: Schrock, Alexa B.; Lee, Jessica K.; Sandhu, Jaideep; Madison, Russell; Cho‐Phan, Cheryl; Snider, Jeremy W.; Castellanos, Emily; Venstrom, Jeffrey M.; Fakih, Marwan Journal: Oncologist Issue: Volume 26:Number 6(2021) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling. (October 2020) Authors: Madison, Russell; Schrock, Alexa B.; Castellanos, Emily; Gregg, Jeffrey P.; Snider, Jeremy; Ali, Siraj M.; Miller, Vincent A.; Singal, Gaurav; Alexander, Brian M.; Venstrom, Jeffrey M.; Chung, Jon H. Journal: Lung cancer Issue: Volume 148(2020) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗